当前位置:首页 - 行情中心 - 春立医疗(688236) - 财务分析 - 利润表

春立医疗

(688236)

  

流通市值:10.97亿  总市值:53.09亿
流通股本:7929.47万   总股本:3.84亿

利润表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
一、营业总收入508,283,661.62380,130,570.92221,850,180.791,208,523,845.88
营业收入508,283,661.62380,130,570.92221,850,180.791,208,523,845.88
二、营业总成本449,469,327.29304,028,844.65164,450,441.62911,961,036.54
营业成本156,043,170.05108,247,815.4658,041,719.59332,635,741.48
税金及附加6,012,961.594,342,874.751,832,378.1810,850,629.27
销售费用163,464,944.14111,481,168.863,145,976.61383,140,145.99
管理费用31,357,332.921,310,062.047,522,645.7244,471,023.1
研发费用99,676,406.767,659,413.0634,991,868.71157,445,504.26
财务费用-7,085,488.09-9,012,489.46-1,084,147.19-16,582,007.56
其中:利息费用27,847.2527,050.23-85,896.45
其中:利息收入8,960,596.258,040,034.971,263,505.1114,461,912.36
加:公允价值变动收益6,079,575.334,670,205.471,380,799.849,610,896.66
加:投资收益9,122,896.796,084,909.583,286,525.2112,012,452.06
资产处置收益39,213.6139,213.61-3,904.6
资产减值损失(新)-9,409,707.93-5,229,285.17-26,245.26-20,707,206.43
信用减值损失(新)-7,060,926.86-5,794,060.61-5,451,806.83-4,315,237.96
其他收益7,865,268.96,413,483.272,736,455.1612,807,845.26
营业利润平衡项目0000
四、营业利润65,450,654.1782,286,192.4259,325,467.29305,975,463.53
加:营业外收入870,286.2856,684.38856,134.36346,862.92
减:营业外支出156,306.2172,914.2517,033416,463.41
利润总额平衡项目0000
五、利润总额66,164,634.1683,069,962.5560,164,568.65305,905,863.04
减:所得税费用5,155,985.694,109,067.775,057,505.4428,087,746.56
六、净利润61,008,648.4778,960,894.7855,107,063.21277,818,116.48
持续经营净利润61,008,648.4778,960,894.7855,107,063.21277,818,116.48
归属于母公司股东的净利润61,151,445.5579,026,078.8255,199,616.28277,824,014.12
少数股东损益-142,797.08-65,184.04-92,553.07-5,897.64
(一)基本每股收益0.160.210.140.72
(二)稀释每股收益0.160.210.140.72
九、综合收益总额61,008,648.4778,960,894.7855,107,063.21277,818,116.48
归属于母公司股东的综合收益总额61,151,445.5579,026,078.8255,199,616.28277,824,014.12
归属于少数股东的综合收益总额-142,797.08-65,184.04-92,553.07-5,897.64
公告日期2024-10-312024-08-312024-04-302024-03-29
审计意见(境内)标准无保留意见
TOP↑